Bayer Receives FDA Warning Over Bayer Aspirin Warning

The FDA issued warnings yesterday to Bayer over marketing linked to two aspirin medicines, saying that Bayer Women’s Low Dose Aspirin Plus Calcium and Bayer Aspirin With Health Advantage had been marketed medical claims for which there is no evidence. The FDA said it intends to take further action against Bayer for the violations.

Contact Information